Background: Recently, identification of independent risk factors for ischemic stroke in
Japanese non-valvular atrial fibrillation (NVAF) patients was made by analyzing the 5 major …

The CHADS 2 score is a validated clinical tool used for the risk stratification of stroke in the
presence of atrial fibrillation (AF). Recently, some studies have shown that CHADS 2 score …

The current atrial fibrillation (AF) management guidelines wisely indicate that oral
anticoagulant (OAC) therapy 'should be considered'(Class IIa) in patients with CHA2DS2 …

Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, which is currently
estimated by clinical characteristics. The cardiac biomarkers N-terminal fragment B-type …

Decision making with regard to thromboprophylaxis should be based upon the absolute
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …

Background: Prior studies show that African-American patients have a higher risk of stroke
compared with Caucasians. Objectives: This study hypothesized addition of African …

Abstract The CHA 2 DS 2-VASc score was developed to improve stroke risk stratification in
atrial fibrillation (AF) patients. We sought to analyze the distribution and prognostic value of …

Background Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of
stroke. Medical therapy for decreasing stroke risk involves anticoagulation, which may …

Atrial fibrillation (AF) is an established independent risk factor for stroke. Current guidelines
regard AF as binary; either present or absent, with the decision for anti-coagulation driven by …

Background: Anticoagulation management of patients with atrial fibrillation (AF) should be
tailored individually on the basis of ischemic stroke risk. The objective of this study was to …